Page last updated: 2024-08-21

alpha-aminopyridine and Insulin Resistance

alpha-aminopyridine has been researched along with Insulin Resistance in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (14.29)29.6817
2010's11 (78.57)24.3611
2020's1 (7.14)2.80

Authors

AuthorsStudies
Arner, EN; Brekken, RA; Cruz, VH; Scherer, PE; Wynne, KW1
Adams, SE; Brooks, AES; Jaiswal, JK; Jamieson, SMF; Masson, SW; Merry, TL; Shepherd, PR1
Calay, ES; Hotamisligil, GS1
Anthony, J; Bhumra, SK; Deka, N; Kelkar, A; Marita, AR; Mutt, S; Mutt, SJ; Ranjith, V; Sharma, S; Sivaramakrishnan, H; Wilankar, C1
Gao, R; Guo, T; Hu, X; Li, J; Liu, Z; Mei, H; Ming, Y; Song, Y; Wang, B; Wu, C; Xiao, L; Xiao, X; Zhang, Y1
Ahmadian, M; Chang, L; Downes, M; Evans, RM; Korytnaya, E; Krause, DM; Liddle, C; Lumeng, CN; Neidert, A; Oral, EA; Peng, X; Poirier, B; Reilly, SM; Saltiel, AR; Uhm, M; Yu, RT; Zamarron, BF1
Choi, SH; Durrance, ES; Jang, HC; Jin, H; Kim, KM; Kim, YB; Lee, GY; Lee, KS; Lim, S; Park, HS; Park, KS1
Chen, H; Chen, Z; Dong, H; Huang, C; Li, G; Li, X; Luo, D; Sun, L; Sun, S; Wei, S; Yang, H; Zhou, Y1
Albrecht-Küpper, B; Dinh, W; Gheorghiade, M; Sabbah, HN; van der Laan, M; Voors, AA1
Baeck, C; Federici, M; Kahles, F; Kappel, B; Lebherz, C; Lehrke, M; Marx, N; Möllmann, J; Tacke, F; Werner, C1
Black, SC; Briscoe, CP; Chen, P; Cho, H; Fraser, J; Kelly-Sullivan, D; Looper, D; McDonnell, SR; Ogilvie, KM; Shi, M; Siegel, K; Timofeevski, S; Yie, J; Yu, XH1
Chang, L; Chiang, SH; Decker, SJ; Downes, M; Evans, RM; Hochberg, I; Larsen, MJ; Li, P; Liddle, C; Mowers, J; Oh, D; Olefsky, JM; Reilly, SM; Rubin, JR; Saltiel, AR; Uhm, M; White, NM; Yu, RT1
Goff, D; Hammond, ME; Harrison, SD; Henriksen, EJ; Johnson, KW; Kinnick, TR; Ma, ST; Nuss, JM; Reeder, JW; Ring, DB; Samuels, I; Slabiak, T; Wagman, AS1

Reviews

1 review(s) available for alpha-aminopyridine and Insulin Resistance

ArticleYear
Partial Adenosine A1 Agonist in Heart Failure.
    Handbook of experimental pharmacology, 2017, Volume: 243

    Topics: Adenosine; Adenosine A1 Receptor Agonists; Aminopyridines; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Coronary Artery Disease; Diabetes Mellitus; Dipeptides; Drug Partial Agonism; Furans; Heart; Heart Failure; Humans; Insulin Resistance; Ischemic Preconditioning, Myocardial; Lipolysis; Mitochondria, Heart; Myocardium; Oxygen Consumption; Pyridines; Renal Insufficiency; Tachycardia, Supraventricular; Thiazoles

2017

Trials

1 trial(s) available for alpha-aminopyridine and Insulin Resistance

ArticleYear
A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis.
    Nature communications, 2015, Jan-12, Volume: 6

    Topics: 3T3-L1 Cells; Adipocytes; Adult; Aged; Aminopyridines; Animals; Cyclic AMP; Female; Gene Knockdown Techniques; Gluconeogenesis; Glucose-6-Phosphatase; Humans; Inflammation; Insulin Resistance; Interleukin-6; Liver; Male; Mice; Mice, Inbred C57BL; Middle Aged; p38 Mitogen-Activated Protein Kinases; Receptors, Adrenergic, beta; Signal Transduction; STAT3 Transcription Factor; Subcutaneous Fat; Young Adult

2015

Other Studies

12 other study(ies) available for alpha-aminopyridine and Insulin Resistance

ArticleYear
Loss of Tbk1 kinase activity protects mice from diet-induced metabolic dysfunction.
    Molecular metabolism, 2018, Volume: 16

    Topics: Aminopyridines; Animals; Body Weight; Diet, High-Fat; Disease Models, Animal; Fatty Liver; I-kappa B Kinase; Insulin; Insulin Resistance; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Phosphorylation; Protein Serine-Threonine Kinases; Signal Transduction; Weight Loss

2018
The CSF1 receptor inhibitor pexidartinib (PLX3397) reduces tissue macrophage levels without affecting glucose homeostasis in mice.
    International journal of obesity (2005), 2020, Volume: 44, Issue:1

    Topics: Adipose Tissue; Aminopyridines; Animals; Diet, High-Fat; Glucose; Homeostasis; Insulin Resistance; Macrophages; Mice; Obesity; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor

2020
Turning off the inflammatory, but not the metabolic, flames.
    Nature medicine, 2013, Volume: 19, Issue:3

    Topics: Aminopyridines; Animals; Anti-Obesity Agents; Energy Metabolism; I-kappa B Kinase; Insulin Resistance; Male; Obesity; Protein Serine-Threonine Kinases

2013
Discovery of p1736, a novel antidiabetic compound that improves peripheral insulin sensitivity in mice models.
    PloS one, 2013, Volume: 8, Issue:10

    Topics: Adipocytes; Aminopyridines; Animals; Diabetes Mellitus, Type 2; Drug Discovery; Glucose; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Metformin; Mice; Mice, Mutant Strains; Rosiglitazone; Sulfonamides; Thiazolidinediones

2013
CMHX008, a novel peroxisome proliferator-activated receptor γ partial agonist, enhances insulin sensitivity in vitro and in vivo.
    PloS one, 2014, Volume: 9, Issue:7

    Topics: 3T3-L1 Cells; Adipose Tissue, White; Aminopyridines; Animals; Anti-Inflammatory Agents; Cell Differentiation; Cell Polarity; Diet, High-Fat; Drug Evaluation, Preclinical; Dyslipidemias; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Macrophages; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; PPAR gamma; Rosiglitazone; Thiazolidinediones; Transcriptional Activation

2014
Anti-diabetic efficacy of KICG1338, a novel glycogen synthase kinase-3β inhibitor, and its molecular characterization in animal models of type 2 diabetes and insulin resistance.
    Molecular and cellular endocrinology, 2015, Jul-05, Volume: 409

    Topics: Aminopyridines; Animals; Carboxylic Acids; Diabetes Mellitus, Type 2; Disease Models, Animal; Endoplasmic Reticulum Stress; Gene Expression Regulation; Glucose; Glucose Tolerance Test; Glycogen Synthase Kinase 3; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Mice; Mice, Obese; Rats; Rats, Inbred OLETF; Receptors, Leptin

2015
Arg⁹⁷² insulin receptor substrate-1 inhibits endothelial nitric oxide synthase expression in human endothelial cells by upregulating microRNA-155.
    International journal of molecular medicine, 2015, Volume: 36, Issue:1

    Topics: Adult; Aged; Aminopyridines; Cells, Cultured; Diabetes Mellitus; Enzyme Activation; Female; Human Umbilical Vein Endothelial Cells; Humans; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; MicroRNAs; Middle Aged; Morpholines; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Transfection

2015
The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolism.
    Diabetes, obesity & metabolism, 2017, Volume: 19, Issue:4

    Topics: Aminopyridines; Animals; Benzamides; Cyclic AMP-Dependent Protein Kinases; Cyclopropanes; Diet, High-Fat; Energy Metabolism; Glucose; Insulin Resistance; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Signal Transduction; Weight Gain

2017
Pharmacological characterization of a small molecule inhibitor of c-Jun kinase.
    American journal of physiology. Endocrinology and metabolism, 2008, Volume: 295, Issue:5

    Topics: 3T3-L1 Cells; Adipose Tissue, White; Aminopyridines; Animals; Blood Glucose; Body Weight; Cytokines; Dietary Fats; Eating; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 8; Obesity; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-jun; Tumor Necrosis Factor-alpha; U937 Cells

2008
[COPD and diabetes mellitus. Does pulmonary medication modify blood glucose metabolism?].
    MMW Fortschritte der Medizin, 2011, Mar-17, Volume: 153, Issue:11

    Topics: Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Aminopyridines; Benzamides; Blood Glucose; Cholinergic Antagonists; Cyclopropanes; Diabetes Mellitus, Type 2; Drug Interactions; Humans; Hypoglycemic Agents; Insulin Resistance; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive

2011
An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice.
    Nature medicine, 2013, Volume: 19, Issue:3

    Topics: Aminopyridines; Animals; Anti-Allergic Agents; Anti-Obesity Agents; Cell Line; Diet, High-Fat; Energy Metabolism; Enzyme Activation; Fatty Liver; Glucose Metabolism Disorders; I-kappa B Kinase; Insulin Resistance; Intra-Abdominal Fat; Male; Mice; Mice, Inbred C57BL; Mice, Obese; NF-kappa B; Obesity; Oxygen Consumption; Protein Serine-Threonine Kinases; Weight Loss

2013
Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo.
    Diabetes, 2003, Volume: 52, Issue:3

    Topics: Aminopyridines; Animals; Biological Transport; CHO Cells; Cricetinae; Diabetes Mellitus; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Female; Gene Expression; Glucose; Glycogen Synthase; Glycogen Synthase Kinase 3; Hepatocytes; Humans; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptor, Insulin; Transfection

2003